# Hematopoietic Stem Cell Transplantation From Human Leukocyte Antigen (HLA) Compatible Donor in Ewing Sarcomas and Soft Tissues Sarcomas

> **NCT00998361** · PHASE2 · UNKNOWN · sponsor: **IRCCS Azienda Ospedaliero-Universitaria di Bologna** · enrollment: 140 (actual)

## Conditions studied

- Ewing
- Soft Tissue Sarcoma

## Interventions

- **PROCEDURE:** Allogeneic hemopoietic stem cell transplant

## Key facts

- **NCT ID:** NCT00998361
- **Lead sponsor:** IRCCS Azienda Ospedaliero-Universitaria di Bologna
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-06
- **Primary completion:** 2010-06
- **Final completion:** 2011-06
- **Target enrollment:** 140 (ACTUAL)
- **Last updated:** 2009-10-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00998361

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00998361, "Hematopoietic Stem Cell Transplantation From Human Leukocyte Antigen (HLA) Compatible Donor in Ewing Sarcomas and Soft Tissues Sarcomas". Retrieved via AI Analytics 2026-09-09 from https://api.ai-analytics.org/clinical/NCT00998361. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*